Compare
Utah Medical Products Inc vs Retractable Technologies Inc vs ClearPoint Neuro, Inc. vs SANUWAVE Health, Inc.
| Latest fiscal year | Utah Medical Products Inc UTMD | Retractable Technologies Inc RVP | ClearPoint Neuro, Inc. CLPT | SANUWAVE Health, Inc. SNWV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $38.52M | $38.27M | $36.97M | $44.05M |
| Revenue growth (YoY) | -5.8% | +15.8% | +17.8% | +35.0% |
| Gross margin | 57.1% | 0.1% | 61.4% | 77.1% (computed) |
| Operating margin | 29.6% | -55.3% | -65.4% | 11.2% |
| Net margin | 29.3% | -32.8% | -69.1% | 26.8% |
| Net income | $11.29M | -$12.57M | -$25.54M | $11.81M |
| EPS (Diluted) | $3.48 | -$0.43 | -$0.90 | $0.41 |
| Operating cash flow | $14.69M | -$7.06M | -$23.93M | $3.88M |
| Free cash flow | $14.32M | n/a | -$24.45M | $1.93M |
| Cash & equivalents | $85.76M | $2.59M | $45.92M | $11.96M |
| Total assets | $122.54M | $142.63M | $97.75M | $37.34M |
| Total liabilities | $3.27M | $68.26M | $69.73M | $35.72M |
| Shareholders' equity | $119.27M | $74.38M | $28.02M | $1.62M |
| Return on year-end equity | 9.5% | -16.9% | -91.1% | 729.6% |
| Shares outstanding | 3.19M | 29.94M | 29.37M | 8.59M |
Revenue, most recent five fiscal years
| Fiscal year | Utah Medical Products Inc | Retractable Technologies Inc | ClearPoint Neuro, Inc. | SANUWAVE Health, Inc. |
|---|---|---|---|---|
| Latest | $38.52M Ended 2025-12-31 | $38.27M Ended 2025-12-31 | $36.97M Ended 2025-12-31 | $44.05M Ended 2025-12-31 |
| 1 year earlier | $40.90M Ended 2024-12-31 | $33.05M Ended 2024-12-31 | $31.39M Ended 2024-12-31 | $32.63M Ended 2024-12-31 |
| 2 years earlier | $50.22M Ended 2023-12-31 | $43.60M Ended 2023-12-31 | $23.95M Ended 2023-12-31 | $20.40M Ended 2023-12-31 |
| 3 years earlier | $52.28M Ended 2022-12-31 | $94.82M Ended 2022-12-31 | $20.55M Ended 2022-12-31 | $16.74M Ended 2022-12-31 |
| 4 years earlier | $49.05M Ended 2021-12-31 | $188.38M Ended 2021-12-31 | $16.30M Ended 2021-12-31 | $13.01M Ended 2021-12-31 |